LINC01021 Attenuates Expression and Affects Alternative Splicing of a Subset of p53-Regulated Genes

Kaller,Forné,Imhof,Hermeking
DOI: https://doi.org/10.3390/cancers16091639
2024-04-25
Cancers
Abstract:Background: Loss of the p53-inducible LINC01021 in p53-proficient CRC cell lines results in increased sensitivity to DNA-damaging chemotherapeutics. Here, we comprehensively analyze how LINC01021 affects the p53-induced transcriptional program. Methods: Using a CRISPR/Cas9-approach, we deleted the p53 binding site in the LINC01021 promoter of SW480 colorectal cancer cells and subjected them to RNA-Seq analysis after the activation of ectopic p53. RNA affinity purification followed by mass spectrometry was used to identify proteins associated with LINC01021. Results: Loss of the p53-inducibility of LINC01021 resulted in an ~1.8-fold increase in the number of significantly regulated mRNAs compared to LINC01021 wild-type cells after ectopic activation of p53. A subset of direct p53 target genes, such as NOXA and FAS, displayed significantly stronger induction when the p53-inducibility of LINC01021 was abrogated. Loss of the p53-inducibility of LINC01021 resulted in alternative splicing of a small number of mRNAs, such as ARHGAP12, HSF2, and LYN. Several RNA binding proteins involved in pre-mRNA splicing were identified as interaction partners of LINC01021 by mass spectrometry. Conclusions: Our results suggest that LINC01021 may restrict the extent and strength of p53-mediated transcriptional changes via context-dependent regulation of the expression and splicing of a subset of p53-regulated genes.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role of long non - coding RNA (lncRNA) LINC01021 in the p53 - induced transcription program. Specifically, the researchers want to understand how LINC01021 affects the expression and splicing of p53 - regulated genes. By using CRISPR/Cas9 technology to delete the p53 - binding site of LINC01021 in SW480 colorectal cancer cells and conducting RNA - sequencing analysis, the researchers found that LINC01021 can weaken the degree and intensity of p53 - mediated transcriptional changes, especially having a more significant impact on some direct p53 target genes after p53 activation. In addition, the deletion of LINC01021 also led to alternative splicing changes in a small number of mRNAs. These results provide a comprehensive framework and resource for the downstream functions of LINC01021 in p53, laying the foundation for further research on its mechanism.